Trimarchi H[au] - Search Results

Year	Number of Results
1999	5
2000	3
2001	3
2002	3
2003	1
2004	2
2005	4
2006	2
2007	4
2008	4
2009	2
2010	4
2011	7
2012	3
2013	7
2014	3
2015	4
2016	7
2017	7
2018	3
2019	4
2020	13
2021	2

1

Oxford Classification of IgA nephropathy 2016: an update from the IgA Nephropathy Classification Working Group.

Trimarchi H, Barratt J, Cattran DC, Cook HT, Coppo R, Haas M, Liu ZH, Roberts IS, Yuzawa Y, Zhang H, Feehally J; IgAN Classification Working Group of the International IgA Nephropathy Network and the Renal Pathology Society; Conference Participants. Trimarchi H, et al. Kidney Int. 2017 May;91(5):1014-1021. doi: 10.1016/j.kint.2017.02.003. Epub 2017 Mar 22. Kidney Int. 2017. PMID: 28341274 Free article. Review.

2

Eculizumab, SARS-CoV-2 and atypical hemolytic uremic syndrome.

Trimarchi H, Gianserra R, Lampo M, Monkowski M, Lodolo J. Trimarchi H, et al. Clin Kidney J. 2020 Sep 27;13(5):739-741. doi: 10.1093/ckj/sfaa166. eCollection 2020 Oct. Clin Kidney J. 2020. PMID: 33117528 Free PMC article.

3

A Multicenter Study of the Predictive Value of Crescents in IgA Nephropathy.

Haas M, Verhave JC, Liu ZH, Alpers CE, Barratt J, Becker JU, Cattran D, Cook HT, Coppo R, Feehally J, Pani A, Perkowska-Ptasinska A, Roberts IS, Soares MF, Trimarchi H, Wang S, Yuzawa Y, Zhang H, Troyanov S, Katafuchi R. Haas M, et al. Among authors: trimarchi h. J Am Soc Nephrol. 2017 Feb;28(2):691-701. doi: 10.1681/ASN.2016040433. Epub 2016 Sep 9. J Am Soc Nephrol. 2017. PMID: 27612994 Free PMC article.

4

Fabry disease and COVID-19: international expert recommendations for management based on real-world experience.

Laney DA, Germain DP, Oliveira JP, Burlina AP, Cabrera GH, Hong GR, Hopkin RJ, Niu DM, Thomas M, Trimarchi H, Wilcox WR, Politei JM, Ortiz A. Laney DA, et al. Among authors: trimarchi h. Clin Kidney J. 2020 Dec 24;13(6):913-925. doi: 10.1093/ckj/sfaa227. eCollection 2020 Dec. Clin Kidney J. 2020. PMID: 33391734 Free PMC article.

5

Why Target the Gut to Treat IgA Nephropathy?

Barratt J, Rovin BH, Cattran D, Floege J, Lafayette R, Tesar V, Trimarchi H, Zhang H; NefIgArd Study Steering Committee. Barratt J, et al. Among authors: trimarchi h. Kidney Int Rep. 2020 Aug 20;5(10):1620-1624. doi: 10.1016/j.ekir.2020.08.009. eCollection 2020 Oct. Kidney Int Rep. 2020. PMID: 33102954 Free PMC article. No abstract available.

6

COVID-19 and acute kidney injury in pediatric subjects: is there a place for eculizumab treatment?

Trimarchi H, Coppo R. Trimarchi H, et al. J Nephrol. 2020 Dec;33(6):1119-1120. doi: 10.1007/s40620-020-00859-1. J Nephrol. 2020. PMID: 32996110 Free PMC article. No abstract available.

7

Podocyturia: Potential applications and current limitations.

Trimarchi H. Trimarchi H. World J Nephrol. 2017 Sep 6;6(5):221-228. doi: 10.5527/wjn.v6.i5.221. World J Nephrol. 2017. PMID: 28948159 Free PMC article. Review.

8

The implications of focal segmental glomerulosclerosis in children with IgA nephropathy.

Trimarchi H, Coppo R. Trimarchi H, et al. Pediatr Nephrol. 2020 Nov;35(11):2043-2047. doi: 10.1007/s00467-019-04414-4. Epub 2019 Nov 26. Pediatr Nephrol. 2020. PMID: 31773265 Review.

9

Mechanisms of Podocyte Detachment, Podocyturia, and Risk of Progression of Glomerulopathies.

Trimarchi H. Trimarchi H. Kidney Dis (Basel). 2020 Sep;6(5):324-329. doi: 10.1159/000507997. Epub 2020 May 27. Kidney Dis (Basel). 2020. PMID: 33490112 Free article. Review.

10

Podocytopathy in the mesangial proliferative immunoglobulin A nephropathy: new insights into the mechanisms of damage and progression.

Trimarchi H, Coppo R. Trimarchi H, et al. Nephrol Dial Transplant. 2019 Aug 1;34(8):1280-1285. doi: 10.1093/ndt/gfy413. Nephrol Dial Transplant. 2019. PMID: 30698804 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results